JP2008539268A5 - - Google Patents

Download PDF

Info

Publication number
JP2008539268A5
JP2008539268A5 JP2008509129A JP2008509129A JP2008539268A5 JP 2008539268 A5 JP2008539268 A5 JP 2008539268A5 JP 2008509129 A JP2008509129 A JP 2008509129A JP 2008509129 A JP2008509129 A JP 2008509129A JP 2008539268 A5 JP2008539268 A5 JP 2008539268A5
Authority
JP
Japan
Prior art keywords
compound
salt
och
carbon
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008509129A
Other languages
English (en)
Other versions
JP2008539268A (ja
JP5049267B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/016059 external-priority patent/WO2006116615A1/en
Publication of JP2008539268A publication Critical patent/JP2008539268A/ja
Publication of JP2008539268A5 publication Critical patent/JP2008539268A5/ja
Application granted granted Critical
Publication of JP5049267B2 publication Critical patent/JP5049267B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

代表的な化合物の睡眠パラメータを、以下に示す。
Figure 2008539268

Figure 2008539268
Figure 2008539268


Figure 2008539268

Claims (12)

  1. 式IVの化合物またはその薬理学的に有効な塩:
    Figure 2008539268
    (IV)
    [式中、
    tは1または2であり;
    1、R2、R3およびR4は、独立してH、F、Cl、Br、CF3、CH3、OH、OCH3、CH2OCH3またはCH2OCH2CH3であり;
    5−R6はH、CH3、CH2CH3であるか、またはR5およびR6は、それらが結合する炭素と一緒になって、3〜7員のスピロ環を形成し;
    ZはCO2Hである]。
  2. 1、R2、R3およびR4の各々がHである、請求項1に記載の化合物。
  3. 1、R3およびR4の各々がHである、請求項1に記載の化合物。
  4. 1、R2およびR4の各々がHである、請求項1に記載の化合物。
  5. 5およびR6の各々がメチルである、請求項1に記載の化合物。
  6. 5およびR6が、それらが結合する炭素と一緒になって、スピロシクロプロピル環を形成する、請求項1に記載の化合物。
  7. tが1である、請求項1〜6のいずれか1項に記載の化合物。
  8. 化合物が式:
    Figure 2008539268
    で示される、請求項1に記載の化合物またはその塩。
  9. 塩が塩酸塩である、請求項8に記載の塩。
  10. 請求項1〜9のいずれか1項に記載の化合物またはその塩と、少なくとも1つの薬理学的に許容できる賦形剤とを含む、医薬組成物。
  11. 睡眠障害の治療用薬剤の製造における、請求項1〜9のいずれか1項に記載の化合物の使用。
  12. 睡眠障害が不眠症である、請求項11記載の使用。
JP2008509129A 2005-04-26 2006-04-26 ベンズイソオキサゾールピペラジン化合物およびその使用方法 Expired - Fee Related JP5049267B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67520205P 2005-04-26 2005-04-26
US60/675,202 2005-04-26
PCT/US2006/016059 WO2006116615A1 (en) 2005-04-26 2006-04-26 Benzisoxazole piperazine compounds and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2008539268A JP2008539268A (ja) 2008-11-13
JP2008539268A5 true JP2008539268A5 (ja) 2012-07-26
JP5049267B2 JP5049267B2 (ja) 2012-10-17

Family

ID=36754209

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008509128A Pending JP2008539267A (ja) 2005-04-26 2006-04-26 ベンズイソオキサゾールピペリジン化合物及びその使用方法
JP2008509129A Expired - Fee Related JP5049267B2 (ja) 2005-04-26 2006-04-26 ベンズイソオキサゾールピペラジン化合物およびその使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008509128A Pending JP2008539267A (ja) 2005-04-26 2006-04-26 ベンズイソオキサゾールピペリジン化合物及びその使用方法

Country Status (15)

Country Link
US (3) US7494998B2 (ja)
EP (2) EP1877405B1 (ja)
JP (2) JP2008539267A (ja)
CN (1) CN101208314B (ja)
AT (2) ATE461925T1 (ja)
AU (1) AU2006239302B2 (ja)
CA (2) CA2606471C (ja)
CY (1) CY1110026T1 (ja)
DE (2) DE602006012650D1 (ja)
DK (1) DK1877390T3 (ja)
ES (2) ES2340066T3 (ja)
MX (1) MX2007013352A (ja)
PL (1) PL1877390T3 (ja)
PT (1) PT1877390E (ja)
WO (1) WO2006116614A1 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004000260T2 (de) 2003-07-22 2006-08-24 Arena Pharmaceuticals, Inc., San Diego Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
PE20061130A1 (es) 2004-11-19 2007-01-05 Arena Pharm Inc Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
ATE461925T1 (de) * 2005-04-26 2010-04-15 Hypnion Inc Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
EP3395816A1 (en) 2006-05-18 2018-10-31 Arena Pharmaceuticals, Inc. Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
ES2536762T3 (es) 2006-05-18 2015-05-28 Arena Pharmaceuticals, Inc. Aminas primarias y sus derivados como moduladores del receptor de la serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con este
CA2646081C (en) 2006-05-18 2017-06-27 Arena Pharmaceuticals, Inc. Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
US7762006B2 (en) * 2006-06-14 2010-07-27 Siestamed, Technologies Medical equipment drying device
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
US9220837B2 (en) * 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
CN104069567A (zh) * 2007-03-19 2014-10-01 茵苏莱恩医药有限公司 药物输送设备
WO2008114220A2 (en) * 2007-03-19 2008-09-25 Insuline Medical Ltd. Device for drug delivery and associated connections thereto
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
WO2009023253A2 (en) 2007-08-15 2009-02-19 Arena Pharmaceuticals Inc. IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2009126830A2 (en) * 2008-04-09 2009-10-15 Surmodics, Inc. Delivery of nucleic acid complexes from materials including negatively charged groups
EP2116618A1 (en) 2008-05-09 2009-11-11 Agency for Science, Technology And Research Diagnosis and treatment of Kawasaki disease
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
ES2666324T3 (es) 2008-10-28 2018-05-04 Arena Pharmaceuticals, Inc. Composiciones de un modulador del receptor de serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con el mismo
MX2011004817A (es) 2008-11-07 2011-07-28 Insuline Medical Ltd Dispositivo y metodo para suministrar farmacos.
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US8980891B2 (en) 2009-12-18 2015-03-17 Arena Pharmaceuticals, Inc. Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
US8565107B2 (en) 2010-09-24 2013-10-22 Hand Held Products, Inc. Terminal configurable for use within an unknown regulatory domain
JP2018516992A (ja) 2015-06-12 2018-06-28 アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
RU2018103338A (ru) 2015-07-15 2019-08-15 Аксовант Сайенсиз Гмбх Производные диарил- и арилгетероарилмочевины для профилактики и лечения галлюцинаций, ассоциированных с нейродегенеративным заболеванием
JPWO2021132311A1 (ja) * 2019-12-24 2021-07-01

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3331541A (en) * 1965-06-07 1967-07-18 Bell & Howell Co Sprocketless projector
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
FR2654104B1 (fr) 1989-11-07 1992-01-03 Adir Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DK60593D0 (da) 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
AU3261097A (en) 1996-06-21 1998-01-14 Glaxo Group Limited Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
KR100588249B1 (ko) * 1997-12-25 2006-06-13 메이지 세이카 가부시키가이샤 테트라하이드로벤즈인돌 유도체
US6605623B1 (en) 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6331541B1 (en) 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
ATE412638T1 (de) 2001-02-16 2008-11-15 Aventis Pharma Inc Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
ES2201899B1 (es) * 2002-04-01 2005-06-01 Almirall Prodesfarma, S.A. Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
ATE461925T1 (de) * 2005-04-26 2010-04-15 Hypnion Inc Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung

Similar Documents

Publication Publication Date Title
JP2008539268A5 (ja)
JP2008539267A5 (ja)
JP2008513510A5 (ja)
JP2010077141A5 (ja)
JP2007514005A5 (ja)
JP2012532874A5 (ja)
JP2010509379A5 (ja)
JP2013519675A5 (ja)
JP2011522816A5 (ja)
JP2009502743A5 (ja)
JP2008531558A5 (ja)
JP2010504343A5 (ja)
JP2015505296A5 (ja)
JP2006182786A5 (ja)
JP2010518061A5 (ja)
JP2010503688A5 (ja)
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
JP2007508361A5 (ja)
JP2009517411A5 (ja)
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
JP2009507909A5 (ja)
JP2008512408A5 (ja)
JP2009511568A5 (ja)
JP2013508279A5 (ja)
JP2014530881A5 (ja)